Your browser doesn't support javascript.
loading
Mission, Organization, and Future Direction of the Serological Sciences Network for COVID-19 (SeroNet) Epidemiologic Cohort Studies.
Figueiredo, Jane C; Hirsch, Fred R; Kushi, Lawrence H; Nembhard, Wendy N; Crawford, James M; Mantis, Nicholas; Finster, Laurel; Merin, Noah M; Merchant, Akil; Reckamp, Karen L; Melmed, Gil Y; Braun, Jonathan; McGovern, Dermot; Parekh, Samir; Corley, Douglas A; Zohoori, Namvar; Amick, Benjamin C; Du, Ruofei; Gregersen, Peter K; Diamond, Betty; Taioli, Emanuela; Sariol, Carlos; Espino, Ana; Weiskopf, Daniela; Gifoni, Alba; Brien, James; Hanege, William; Lipsitch, Marc; Zidar, David A; Scheck McAlearney, Ann; Wajnberg, Ania; LaBaer, Joshua; Yvonne Lewis, E; Binder, Raquel A; Moormann, Ann M; Forconi, Catherine; Forrester, Sarah; Batista, Jennifer; Schieffelin, John; Kim, Dongjoo; Biancon, Giulia; VanOudenhove, Jennifer; Halene, Stephanie; Fan, Rong; Barouch, Dan H; Alter, Galit; Pinninti, Swetha; Boppana, Suresh B; Pati, Sunil K; Latting, Misty.
Afiliación
  • Figueiredo JC; Department of Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.
  • Hirsch FR; Department of Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Kushi LH; Division of Research, Kaiser Permanente Northern California, Oakland, California, USA.
  • Nembhard WN; Fay W. Boozman College of Public Health, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
  • Crawford JM; Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York, USA.
  • Mantis N; Division of Infectious Diseases Wadsworth Center, New York State Department of Health, New York, New York, USA.
  • Finster L; Department of Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.
  • Merin NM; Division of Hematology and Cellular Therapy, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.
  • Merchant A; Division of Hematology and Cellular Therapy, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.
  • Reckamp KL; Department of Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.
  • Melmed GY; F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.
  • Braun J; F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.
  • McGovern D; F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.
  • Parekh S; Department of Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Corley DA; Division of Research, Kaiser Permanente Northern California, Oakland, California, USA.
  • Zohoori N; Fay W. Boozman College of Public Health, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
  • Amick BC; Fay W. Boozman College of Public Health, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
  • Du R; Fay W. Boozman College of Public Health, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
  • Gregersen PK; Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York, USA.
  • Diamond B; Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York, USA.
  • Taioli E; Department of Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Sariol C; Unit of Comparative Medicine, University of Puerto Rico, Medical Sciences, San Juan, Puerto Rico, USA.
  • Espino A; Unit of Comparative Medicine, University of Puerto Rico, Medical Sciences, San Juan, Puerto Rico, USA.
  • Weiskopf D; La Jolla Institute of Immunology, La Jolla, California, USA.
  • Gifoni A; La Jolla Institute of Immunology, La Jolla, California, USA.
  • Brien J; Department of Molecular Microbiology and Immunology, Saint Louis University, St. Louis, Missouri, USA.
  • Hanege W; Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard TH Chan School of Public Health, Bethesda, Maryland, USA.
  • Lipsitch M; Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard TH Chan School of Public Health, Bethesda, Maryland, USA.
  • Zidar DA; Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
  • Scheck McAlearney A; Department of Family and Community Medicine, Ohio State University College of Medicine, Columbus, Ohio, USA.
  • Wajnberg A; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • LaBaer J; Biodesign Virginia G. Piper Center for Personalized Diagnostics, Arizona State University, Tempe, Arizona, USA.
  • Yvonne Lewis E; Department of Public Health, Michigan State University, Flint, Michigan, USA.
  • Binder RA; Department of Medicine, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.
  • Moormann AM; Department of Medicine, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.
  • Forconi C; Department of Medicine, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.
  • Forrester S; Department of Population and Quantitative Health Sciences, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.
  • Batista J; Department of Population and Quantitative Health Sciences, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.
  • Schieffelin J; Department of Pediatrics, Tulane University School of Medicine, New Orleans, Louisiana, USA.
  • Kim D; Department of Biomedical Engineering, Yale University, New Haven, Connecticut, USA.
  • Biancon G; Section of Hematology, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
  • VanOudenhove J; Section of Hematology, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
  • Halene S; Section of Hematology, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
  • Fan R; Department of Biomedical Engineering, Yale University, New Haven, Connecticut, USA.
  • Barouch DH; The Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
  • Alter G; Ragon Institute, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
  • Pinninti S; Departments of Pediatrics, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Boppana SB; Departments of Pediatrics, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Pati SK; Departments of Pediatrics, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Latting M; Departments of Pediatrics, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Open Forum Infect Dis ; 9(6): ofac171, 2022 Jun.
Article en En | MEDLINE | ID: mdl-35765315
Background: Global efforts are needed to elucidate the epidemiology of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the underlying cause of coronavirus disease 2019 (COVID-19), including seroprevalence, risk factors, and long-term sequelae, as well as immune responses after vaccination across populations and the social dimensions of prevention and treatment strategies. Methods: In the United States, the National Cancer Institute in partnership with the National Institute of Allergy and Infectious Diseases, established the SARS-CoV-2 Serological Sciences Network (SeroNet) as the nation's largest coordinated effort to study coronavirus disease 2019. The network comprises multidisciplinary researchers bridging gaps and fostering collaborations among immunologists, epidemiologists, virologists, clinicians and clinical laboratories, social and behavioral scientists, policymakers, data scientists, and community members. In total, 49 institutions form the SeroNet consortium to study individuals with cancer, autoimmune disease, inflammatory bowel diseases, cardiovascular diseases, human immunodeficiency virus, transplant recipients, as well as otherwise healthy pregnant women, children, college students, and high-risk occupational workers (including healthcare workers and first responders). Results: Several studies focus on underrepresented populations, including ethnic minorities and rural communities. To support integrative data analyses across SeroNet studies, efforts are underway to define common data elements for standardized serology measurements, cellular and molecular assays, self-reported data, treatment, and clinical outcomes. Conclusions: In this paper, we discuss the overarching framework for SeroNet epidemiology studies, critical research questions under investigation, and data accessibility for the worldwide scientific community. Lessons learned will help inform preparedness and responsiveness to future emerging diseases.
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Idioma: En Revista: Open Forum Infect Dis Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Idioma: En Revista: Open Forum Infect Dis Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos